ACRS vs NUE · rev $3.6M vs P/E 25, rev $19.89B
Aclaris Therapeutics Inc (ACRS) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
ACRS currently screens at market cap $615.9M. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the ACRS and NUE stock pages for the full models.
Not investment advice.